[CYCC] YoY Quarter Result on 30-Jun-2013 [#Q2]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
14-Aug-2013
Financial Year
2013
Quarter
30-Jun-2013 [#Q2]
Profit Trend
QoQ- 146.37%
YoY- 139.95%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
Revenue 222 296 356 264 146 168 119 10.94%
PBT -3,591 -3,752 -5,635 1,248 -3,704 -3,678 -4,163 -2.43%
Tax -626 -405 -816 -230 -127 -126 -230 18.14%
NP -2,965 -3,347 -4,812 1,429 -3,577 -3,552 -3,933 -4.59%
Tax Rate - - - 18.43% - - - -
Total Cost 3,187 3,643 5,168 -1,165 3,723 3,720 4,052 -3.91%
Ratio Analysis
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
NP Margin -1,335.59 -1,130.74 -1,351.69 541.29 -2,450.00 -2,114.29 -3,305.04 -14.00%
Per Share
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
EPS -19.77 -23.36 -51.14 24.00 -101.86 -128.11 -180.70 -30.81%
EPS Diluted -19.77 -23.36 -51.14 24.00 -101.86 -128.11 -180.70 -30.81%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.